Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting entities : Atyr pharma, inc. save search
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.05%
H: 1.04%
C: -0.52%
atyr2810 pharma treatment tumor research preclinical meeting therapy growth
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies
Published: 2023-03-20 (Crawled : 14:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 4.26%
H: 1.62%
C: -2.04%
pharma research meeting
aTyr Pharma Presents Preclinical Research Characterizing Effects of ATYR2810 in Highly Aggressive Tumor Subtypes at the 2022 AACR Annual Meeting
Published: 2022-04-11 (Crawled : 14:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -1.38%
H: 1.0%
C: -2.2%
atyr2810 pharma research preclinical pre-clinical
aTyr Pharma Announces Positive End-of-Phase 2 Meeting with FDA on Efzofitimod for the Treatment of Pulmonary Sarcoidosis
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 3.62%
H: 6.6%
C: 2.33%
treatment fda phase 2 pos positive
aTyr Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
america pos research presentation cancer pharma
aTyr Pharma Presents Research Demonstrating Effects of Novel NRP2-Targeting Antibody, ATYR2810, on Tumor Associated Macrophages at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-09 (Crawled : 17:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.47%
H: 2.73%
C: 2.02%
immunotherapy therapy cancer antibody research
aTyr Pharma Announces Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.55%
H: 0.74%
C: -5.2%
presentation immunotherapy therapy cancer pharma
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Steroids and SarcoidosisPanel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00pm PT
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.66%
research
aTyr Pharma Presents Preclinical Research Showing Effects of ATYR2810 in Lung and Breast Cancer at the 2021 AACR Virtual Annual Meeting
Published: 2021-04-09 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -1.62%
H: 9.18%
C: 5.88%
cancer research breast cancer preclinical pre-clinical
aTyr Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-03-11 (Crawled : 14:32) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 6.7%
H: 3.9%
C: 3.68%
cancer research pharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.